Diagnostics & Research
The Diagnostics & Research industry has a total of 47 stocks, with a combined market cap of $642.47 billion, total revenue of $167.1 billion and a weighted average PE ratio of 35.76.
Market Cap
642.47B
Revenue
167.1B
Profits
17.96B
PE Ratio
35.76
Profit Margin
10.75%
Dividend Yield
0.25%
47 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 177.99B | 2.72% | 2,161,330 | 45.20B |
| 2 | DHR | Danaher Corporation | 126.66B | 0.08% | 5,142,692 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.54B | 1.29% | 717,072 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 32.65B | 3.82% | 2,236,999 | 7.07B |
| 5 | WAT | Waters Corporation | 30.36B | 5.85% | 1,173,513 | 3.17B |
| 6 | NTRA | Natera, Inc. | 29.44B | 5.86% | 1,772,737 | 2.31B |
| 7 | IQV | IQVIA Holdings Inc. | 26.58B | 1.09% | 2,518,914 | 16.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 25.85B | 2.94% | 147,808 | 4.03B |
| 9 | DGX | Quest Diagnostics Incorporated | 21.50B | 2.58% | 1,109,986 | 11.28B |
| 10 | LH | Labcorp Holdings Inc. | 21.11B | -0.13% | 1,528,487 | 14.14B |
| 11 | ILMN | Illumina, Inc. | 19.25B | 5.29% | 2,415,173 | 4.39B |
| 12 | MEDP | Medpace Holdings, Inc. | 11.96B | 1.23% | 331,921 | 2.68B |
| 13 | GH | Guardant Health, Inc. | 11.42B | 4.40% | 2,708,422 | 982.02M |
| 14 | RVTY | Revvity, Inc. | 9.68B | 5.30% | 987,612 | 2.86B |
| 15 | ICLR | ICON Public Limited Company | 9.04B | 1.86% | 1,561,247 | 8.10B |
| 16 | CRL | Charles River Laboratories International, Inc. | 8.24B | 1.91% | 702,855 | 4.02B |
| 17 | QGEN | Qiagen N.V. | 7.15B | 2.89% | 4,411,316 | 2.09B |
| 18 | SHC | Sotera Health Company | 4.44B | 0.71% | 2,962,916 | 1.16B |
| 19 | RDNT | RadNet, Inc. | 4.43B | 1.18% | 725,979 | 2.04B |
| 20 | TWST | Twist Bioscience Corporation | 3.58B | 3.09% | 1,552,585 | 391.56M |
| 21 | BLLN | BillionToOne, Inc. | 3.45B | 1.82% | 445,610 | 305.11M |
| 22 | VCYT | Veracyte, Inc. | 2.63B | 3.59% | 704,999 | 517.15M |
| 23 | GRAL | GRAIL, Inc. | 2.23B | 9.64% | 670,348 | 147.17M |
| 24 | WGS | GeneDx Holdings Corp. | 1.84B | -0.02% | 763,548 | 427.54M |
| 25 | NEO | NeoGenomics, Inc. | 1.21B | 3.35% | 3,207,485 | 745.97M |
| 26 | CDNA | CareDx, Inc. | 1.08B | 0.05% | 997,394 | 412.82M |
| 27 | OPK | OPKO Health, Inc. | 849.48M | 1.35% | 2,634,643 | 581.12M |
| 28 | CSTL | Castle Biosciences, Inc. | 741.95M | 1.03% | 350,639 | 344.23M |
| 29 | PSNL | Personalis, Inc. | 577.82M | 9.52% | 5,643,486 | 69.65M |
| 30 | MYGN | Myriad Genetics, Inc. | 448.60M | 1.50% | 1,010,270 | 824.50M |
| 31 | FLGT | Fulgent Genetics, Inc. | 438.15M | 2.64% | 572,465 | 322.67M |
| 32 | PRE | Prenetics Global Limited | 281.20M | -4.02% | 197,846 | 92.39M |
| 33 | BNR | Burning Rock Biotech Limited | 183.03M | 4.68% | 62,271 | 77.14M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 128.99M | 4.70% | 93,996 | 4.06M |
| 35 | FONR | FONAR Corporation | 124.10M | -0.05% | 40,208 | 106.03M |
| 36 | BDSX | Biodesix, Inc. | 110.98M | 11.59% | 101,818 | 88.50M |
| 37 | MDXH | MDxHealth SA | 104.78M | 3.55% | 208,377 | 107.88M |
| 38 | XGN | Exagen Inc. | 69.75M | 5.07% | 308,962 | 66.58M |
| 39 | PRPO | Precipio, Inc. | 55.12M | 3.69% | 46,435 | 24.05M |
| 40 | BIAF | bioAffinity Technologies, Inc. | 11.17M | 2.26% | 211,904 | 6.16M |
| 41 | MBAI | Check-Cap Ltd. | 10.71M | 1.38% | 35,883 | - |
| 42 | NOTV | Inotiv, Inc. | 9.98M | -6.12% | 287,164 | 514.03M |
| 43 | XWEL | XWELL, Inc. | 9.35M | 2.61% | 28,123 | 29.21M |
| 44 | ADVB | Advanced Biomed Inc. | 7.30M | 0.94% | 12,147 | - |
| 45 | NDRA | ENDRA Life Sciences Inc. | 6.04M | 0.41% | 9,679 | - |
| 46 | QUCY | Mainz Biomed N.V. | 5.34M | -6.65% | 1,247,197 | 537.08K |
| 47 | ISPC | iSpecimen Inc. | 3.88M | 22.48% | 2,030,096 | 1.93M |